September 24, 2024
Otsuka Pharmaceutical Co., Ltd.
National Cancer Center Japan
Kyushu University
Kyoto University
Nagoya Medical Center, National Hospital Organization
The Institute of Medical Science, The University of Tokyo
Keio University School of Medicine
We are pleased to announce that Otsuka Pharmaceutical Co., Ltd. (Head Office: Tokyo; hereinafter "Otsuka Pharmaceutical") has obtained manufacturing and marketing approval in Japan for Hemsite®, a gene panel test for hematologic malignancies. Hemsite® was co-designed by Otsuka Pharmaceutical and the National Cancer Center Japan (Location: Tokyo; hereinafter "NCCJ") and developed by a joint research consortium with the NCCJ, Kyushu University (Location: Fukuoka Prefecture), Kyoto University (Location: Kyoto Prefecture), Nagoya Medical Center, National Hospital Organization (Location: Aichi Prefecture), the Advanced Clinical Research Center at The Institute of Medical Science, The University of Tokyo (Location: Tokyo), and Keio University School of Medicine (Location: Tokyo). Moving forward, we will proceed with procedures for insurance coverage and prepare for its launch.
Please see below for the full press release.